Obsidian Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| OBX | INBX | ONCO.ST | ODTX | IMTX | CTMX | |
|---|---|---|---|---|---|---|
| Market cap | 678.88M | 1.28B | 746.25M | 937.14M | 1.05B | 512.06M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.2 | -9.9 | -2.4 | -4.5 | -3.4 | -5.0 |
| Price/book | -0.8 | -24.1 | 27.5 | -0.1 | 2.1 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −24.40% | −1.45% | −66.03% | +31.36% | −20.86% | −48.22% |
| Today | −16.93% | +7.01% | +0.35% | −9.60% | −2.33% | +7.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All OBX news ›Obsidian Therapeutics (NASDAQ:OBX) Upgraded at Wall Street Zen
Posted by Sarita Garza on Oct 28th, 2026 Wall Street Zen upgraded shares of Obsidian Therapeutics (NASDAQ:OBX – Free Report) from a sell rating to a hold rating in a research report released on Sunday morning,Wall Street Zen reports. View…
Obsidian Therapeutics (OBX) Stock Chart and Price History 2026
$OBX MarketBeat Obsidian Therapeutics (OBX) Stock Chart & Stock Price History Obsidian Therapeutics Stock Price Performance The Obsidian Therapeutics (OBX) stock chart highlights key performance trends across multiple timeframes. In th
Paradigm BioCapital Reports 6.6% Ownership Stake in Obsidian Therapeutics
Kalkine Media On October 5, 2026, Paradigm BioCapital Advisors LP along with affiliated reporting persons submitted a Schedule 13G filing with the SEC, revealing their beneficial ownership in Obsidian Therapeutics, Inc., a bio
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- kalkinemedia.com1
- marketbeat.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.